BTC$62,618.00-0.25%
ETH$1,784.25+0.38%
USDT$0.9988-0.04%
BNB$569.17+0.14%
USDC$0.9999+0.01%
XRP$1.07-0.61%
SOL$75.19-1.62%
TRX$0.3249-1.59%
FIGR_HELOC$1.03+1.91%
HYPE$63.74-2.41%
DOGE$0.0723+0.10%
USDS$0.99970.00%
RAIN$0.0143-0.35%
LEO$9.54+0.05%
ZEC$507.59-1.85%
WBT$54.95-0.04%
BTC$62,618.00-0.25%
ETH$1,784.25+0.38%
USDT$0.9988-0.04%
BNB$569.17+0.14%
USDC$0.9999+0.01%
XRP$1.07-0.61%
SOL$75.19-1.62%
TRX$0.3249-1.59%
FIGR_HELOC$1.03+1.91%
HYPE$63.74-2.41%
DOGE$0.0723+0.10%
USDS$0.99970.00%
RAIN$0.0143-0.35%
LEO$9.54+0.05%
ZEC$507.59-1.85%
WBT$54.95-0.04%
With fresh tax relief and accelerating AI breakthroughs, select U.S. biotechs are entering a rare period of asymmetric upside.
HCW Biologics stock surged 85.5% after announcing a breakthrough second-generation immune checkpoint inhibitor that outperformed existing cancer treatments.
Abivax shares surged over 400% in premarket trading after announcing positive Phase 3 results for its ulcerative colitis drug obefazimod.
Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.
Recursion Pharmaceuticals, Schrodinger, and RadNet are some biotech companies that have used AI to outperform the market.
Notwithstanding further stress caused by viral fears, these three stocks should benefit from a steady recovery.
From woman’s health to online tutoring, these penny stocks have caught the attention of experts in January 2021.
Biotech stocks are inherently fickle, but these two have a great outlook.